NasdaqCM - Nasdaq Real Time Price USD
Monopar Therapeutics Inc. (MNPR)
35.59
+3.48
+(10.84%)
At close: June 4 at 4:00:02 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.63 | -0.64 | -2.55 | -2.13 |
| Low Estimate | -0.71 | -0.74 | -2.56 | -2.59 |
| High Estimate | -0.55 | -0.54 | -2.53 | -1.68 |
| Year Ago EPS | -0.5 | -1.85 | -4.11 | -2.55 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -- | -- | -- | 2.3M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | 5.41M |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.47 | -1.17 | -0.42 | -0.57 |
| EPS Actual | -0.5 | -1.85 | -2.75 | -0.38 |
| Difference | -0.03 | -0.68 | -2.33 | 0.19 |
| Surprise % | -7.14% | -58.12% | -554.76% | 32.94% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.63 | -0.64 | -2.55 | -2.13 |
| 7 Days Ago | -0.62 | -0.71 | -2.63 | -1.94 |
| 30 Days Ago | -0.62 | -0.71 | -2.63 | -1.94 |
| 60 Days Ago | -0.59 | -0.67 | -2.48 | -0.24 |
| 90 Days Ago | -0.59 | -0.67 | -2.48 | -0.24 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | -- |
| Up Last 30 Days | 1 | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MNPR | -26.00% | 65.41% | 38.08% | 16.11% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.97% |
Upgrades & Downgrades
| Downgrade | Jones Trading: Buy to Hold | 4/2/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/1/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 1/22/2025 |
| Initiated | Piper Sandler: Overweight | 1/10/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/11/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 8/14/2024 |
Related Tickers
DRUG Bright Minds Biosciences Inc.
27.55
+0.33%
TLSA Tiziana Life Sciences Ltd
1.4300
+0.70%
CADL Candel Therapeutics, Inc.
5.60
-2.61%
MBIO Mustang Bio, Inc.
1.2900
0.00%
ANAB AnaptysBio, Inc.
21.27
-9.57%
CRVS Corvus Pharmaceuticals, Inc.
3.7500
-8.98%
XCUR Exicure, Inc.
10.15
-2.12%
PVLA Palvella Therapeutics, Inc.
23.81
-2.58%
JANX Janux Therapeutics, Inc.
25.13
-1.18%
SRRK Scholar Rock Holding Corporation
30.82
-0.39%